Immunomodulatory Potential of the Polysaccharide-Rich Extract from Edible Cyanobacterium Nostoc commune.

about

Immunomodulatory Potential of the Polysaccharide-Rich Extract from Edible Cyanobacterium Nostoc commune.

Item

http://www.wikidata.org/entity/Q42705656

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Immunomodulatory Potential of ...... Cyanobacterium Nostoc commune.

@en

Immunomodulatory Potential of ...... Cyanobacterium Nostoc commune.

@nl

type

Item

label

Immunomodulatory Potential of ...... Cyanobacterium Nostoc commune.

@en

Immunomodulatory Potential of ...... Cyanobacterium Nostoc commune.

@nl

prefLabel

Immunomodulatory Potential of ...... Cyanobacterium Nostoc commune.

@en

Immunomodulatory Potential of ...... Cyanobacterium Nostoc commune.

@nl

P1476

Immunomodulatory Potential of ...... Cyanobacterium Nostoc commune.

@en

P2093

Hui-Fen Liao

http://www.w3.org/2001/XMLSchema#string

Jia-Liang Tai

http://www.w3.org/2001/XMLSchema#string

Long-Liu Lin

http://www.w3.org/2001/XMLSchema#string

Meng-Chun Chi

http://www.w3.org/2001/XMLSchema#string

Tai-Jung Wu

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-6: a new therapeutic target

Identification of the ron gene product as the receptor for the human macrophage stimulating protein

The multi-differentiation potential of peripheral blood mononuclear cells

Role of the pro-inflammatory cytokines tumor necrosis factor-alpha, interleukin-1 beta, interleukin-6 and interleukin-8 in the pathogenesis of the otitis media with effusion

IL-17: prototype member of an emerging cytokine family

Cryptophycin: a new antimicrotubule agent active against drug-resistant cells

Trypan blue exclusion test of cell viability

Interleukin-17 in post-stroke neurodegeneration

Emerging applications of recombinant human granulocyte-macrophage colony-stimulating factor

Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.

P304

112-123

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/MEDSCI3040112

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283829361

http://www.w3.org/2001/XMLSchema#string

P698

29083396

http://www.w3.org/2001/XMLSchema#string

P921

polysaccharides

P932

5635763

http://www.w3.org/2001/XMLSchema#string